MAP1LC3B
MOLECULAR TARGETmicrotubule associated protein 1 light chain 3 beta
MAP1LC3B (microtubule associated protein 1 light chain 3 beta) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting MAP1LC3B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Novobiocin | 1.10 | 2 |
About MAP1LC3B as a Drug Target
MAP1LC3B (microtubule associated protein 1 light chain 3 beta) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented MAP1LC3B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
MAP1LC3B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.